Literature DB >> 2501966

Tau, paired helical filaments and amyloid in the neocortex: a morphometric study of 15 cases with graded intellectual status in aging and senile dementia of Alzheimer type.

P Delaère1, C Duyckaerts, J P Brion, V Poulain, J J Hauw.   

Abstract

Tau immunoreactivity was studied in temporal neocortex, area 22, in 15 cases with graded intellectual status and compared with the immunoreactivity observed with an antiserum against paired helical filaments (PHF) and with the density of amyloid revealed by thioflavin S. Samples came from women over 75 years either intellectually normal or affected by senile dementia of the Alzheimer type at various degrees of severity. Mental status had been prospectively assessed by the Blessed's test score. Anti-tau labelled a neuropil meshwork, the density of which increased with the severity of the disease. This meshwork was denser in layers II, III and V in the most affected cases. The number and the size of the tau-positive fibers within the senile plaques increased with the intellectual deficit. Senile plaques were more numerous in layers II and III and neurofibrillary tangles in layers III and V whatever the staining technique: tau or PHF immunocytochemistry, and thioflavin S. The densities of senile plaques and of neurofibrillary tangles (NFT) were correlated with the severity of the disease whatever the staining method. The three methods revealed a systematically different number of changes. This systematic difference could greatly influence the neuropathological diagnosis. It could be the consequence of various factors: different sensitivities of the staining methods or changes in the antigenic and amyloid composition of the lesion according to the stage of the disease. In line with the last hypothesis, a higher proportion of amyloid-rich plaques was noted in the less affected cases, suggesting that tau and PHF epitopes appeared secondarily.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2501966     DOI: 10.1007/bf00687893

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  24 in total

1.  Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments.

Authors:  A Delacourte; A Defossez
Journal:  J Neurol Sci       Date:  1986-12       Impact factor: 3.181

2.  Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease.

Authors:  K S Kosik; C L Joachim; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Tau epitopes are incorporated into a range of lesions in Alzheimer's disease.

Authors:  C L Joachim; J H Morris; D J Selkoe; K S Kosik
Journal:  J Neuropathol Exp Neurol       Date:  1987-11       Impact factor: 3.685

4.  Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences. Microtubule-associated protein tau antigenicity is prominent in all types of tangles.

Authors:  C Bancher; H Lassmann; H Budka; I Grundke-Iqbal; K Iqbal; G Wiche; F Seitelberger; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

5.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

6.  Neurofibrillary tangles of Alzheimer's disease: an immunohistochemical study.

Authors:  J P Brion; A M Couck; E Passareiro; J Flament-Durand
Journal:  J Submicrosc Cytol       Date:  1985-01

Review 7.  [Alzheimer's disease, amyloidosis, microglia and astrocytes].

Authors:  J J Hauw; C Duyckaerts; P Delaere; M P Chaunu
Journal:  Rev Neurol (Paris)       Date:  1988       Impact factor: 2.607

8.  Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer type.

Authors:  C Duyckaerts; J J Hauw; F Bastenaire; F Piette; C Poulain; V Rainsard; F Javoy-Agid; P Berthaux
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

9.  Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease.

Authors:  J Rogers; J H Morrison
Journal:  J Neurosci       Date:  1985-10       Impact factor: 6.167

10.  Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease.

Authors:  C M Wischik; M Novak; H C Thøgersen; P C Edwards; M J Runswick; R Jakes; J E Walker; C Milstein; M Roth; A Klug
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

View more
  20 in total

1.  Neuronal LR11/sorLA expression is reduced in mild cognitive impairment.

Authors:  Kristen L Sager; Joanne Wuu; Susan E Leurgans; Howard D Rees; Marla Gearing; Elliott J Mufson; Allan I Levey; James J Lah
Journal:  Ann Neurol       Date:  2007-12       Impact factor: 10.422

2.  Comparison of four staining methods on the detection of neuritic plaques.

Authors:  H M Wisniewski; G Y Wen; K S Kim
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

3.  AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure.

Authors:  Shruti Mishra; Brian A Gordon; Yi Su; Jon Christensen; Karl Friedrichsen; Kelley Jackson; Russ Hornbeck; David A Balota; Nigel J Cairns; John C Morris; Beau M Ances; Tammie L S Benzinger
Journal:  Neuroimage       Date:  2017-07-26       Impact factor: 6.556

4.  Correlation between microscopical changes and Tau 64 and 69 biochemical detection in senile dementia of the Alzheimer type. Tau 64 and 69 are reliable markers of the neurofibrillary degeneration.

Authors:  S Flament; A Delacourte; P Delaère; C Duyckaerts; J J Hauw
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

5.  Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins.

Authors:  A Delacourte; S Flament; E M Dibe; P Hublau; B Sablonnière; B Hémon; V Shérrer; A Défossez
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.

Authors:  E B Mukaetova-Ladinska; C R Harrington; M Roth; C M Wischik
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

7.  Candidate PET Radioligand Development for Neurofibrillary Tangles: Two Distinct Radioligand Binding Sites Identified in Postmortem Alzheimer's Disease Brain.

Authors:  Lisheng Cai; Baoxi Qu; Bryan T Hurtle; Sureshbabu Dadiboyena; Ramon Diaz-Arrastia; Victor W Pike
Journal:  ACS Chem Neurosci       Date:  2016-05-19       Impact factor: 4.418

8.  Two distinct ubiquitin immunoreactive senile plaques in Alzheimer's disease: relationship with the intellectual status in 29 cases.

Authors:  Y He; P Delaère; C Duyckaerts; M Wasowicz; F Piette; J J Hauw
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 9.  Tau therapeutics for Alzheimer's disease: the promise and the challenges.

Authors:  Michael Gold
Journal:  J Mol Neurosci       Date:  2002-12       Impact factor: 3.444

Review 10.  Behind the curtain of tauopathy: a show of multiple players orchestrating tau toxicity.

Authors:  Yunpeng Huang; Zhihao Wu; Bing Zhou
Journal:  Cell Mol Life Sci       Date:  2015-09-24       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.